ScitoVation

ScitoVation specializes in the development and implementation of advanced methods for chemical safety assessment. The company operates in the chemical discovery and development market, focusing on the use of new alternative methods (NAMs) and computational technologies, such as genomic data and artificial intelligence, to rapidly assess chemical safety. ScitoVation's business model involves collaborating with industry consultants through their Collaborative Partnering Program (CPP), which promotes the use of 21st-century safety assessment methods. By leveraging in vitro and in silico techniques, ScitoVation provides valuable insights that guide additional studies, including study design and potential endpoints. The company primarily serves consultants and their clients who benefit from ScitoVation's expertise in cell-based and computational safety assessment methods. ScitoVation generates revenue by offering these specialized services and forming strategic partnerships with consultants, ensuring a seamless delivery of safety assessment solutions. Keywords: chemical safety, computational methods, cell-based assessment, genomic data, artificial intelligence, in vitro, in silico, safety assessment, consultants, partnerships.